Avidity Biosciences Inc
NASDAQ:RNA

Watchlist Manager
Avidity Biosciences Inc Logo
Avidity Biosciences Inc
NASDAQ:RNA
Watchlist
Price: 29.03 USD -2.68% Market Closed
Market Cap: 3.5B USD

Intrinsic Value

RNA's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one RNA stock under the Base Case scenario is 22.03 USD. Compared to the current market price of 29.03 USD, Avidity Biosciences Inc is Overvalued by 24%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RNA Intrinsic Value
22.03 USD
Overvaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Avidity Biosciences Inc

Valuation History Unavailable

Historical valuation for RNA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare RNA to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RNA?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Avidity Biosciences Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Avidity Biosciences Inc

Current Assets 1.4B
Cash & Short-Term Investments 1.4B
Receivables 36.6m
Other Current Assets 18.5m
Non-Current Assets 24.1m
PP&E 20.6m
Other Non-Current Assets 3.5m
Efficiency

Free Cash Flow Analysis
Avidity Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Avidity Biosciences Inc

Revenue
8.9m USD
Operating Expenses
-442.2m USD
Operating Income
-433.3m USD
Other Expenses
64m USD
Net Income
-369.2m USD
Fundamental Scores

RNA Profitability Score
Profitability Due Diligence

Avidity Biosciences Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional Revenue Growth Forecast
ROIC is Increasing
ROE is Increasing
39/100
Profitability
Score

Avidity Biosciences Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

RNA Solvency Score
Solvency Due Diligence

Avidity Biosciences Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Avidity Biosciences Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RNA Price Targets Summary
Avidity Biosciences Inc

Wall Street analysts forecast RNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RNA is 68.2 USD with a low forecast of 50.5 USD and a high forecast of 100.8 USD.

Lowest
Price Target
50.5 USD
74% Upside
Average
Price Target
68.2 USD
135% Upside
Highest
Price Target
100.8 USD
247% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Avidity Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RNA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

RNA Insider Trading
Buy and sell transactions by insiders

RNA News

Other Videos
What is the Intrinsic Value of one RNA stock?

The intrinsic value of one RNA stock under the Base Case scenario is 22.03 USD.

Is RNA stock undervalued or overvalued?

Compared to the current market price of 29.03 USD, Avidity Biosciences Inc is Overvalued by 24%.

Back to Top